Science Explorer Back to mapMap
Discussion
Researcher · The Francis Crick Institute · United Kingdom

Kevin Litchfield

Kevin Litchfield publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

ORCID 0000-0002-3725-0914 OpenAlex
World rank
#12,965
of 7,710,434 ranked researchers
Rank in United Kingdom
#872
of 367,258
Works
441
Citations
15k
Citations per work
33.6
h-index
53
i10-index 97Top 3.1% in Molecular Biology
Kevin Litchfield

What does Kevin Litchfield research?

Kevin Litchfield's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (29%), Immunology and Microbiology (10%).

Life Sciences: 230 works · 52.1% of their workBiochemistry, Genetics and Molecular Biology: 184 works · 41.7% of their workMolecular Biology: 87 works · 19.7% of their workCancer Research: 76 works · 17.3% of their workGenetics: 21 works · 4.7% of their workImmunology and Microbiology: 46 works · 10.4% of their workImmunology: 46 works · 10.4% of their workHealth Sciences: 130 works · 29.4% of their workMedicine: 130 works · 29.4% of their workOncology: 83 works · 18.8% of their workPulmonary and Respiratory Medicine: 47 works · 10.6% of their workEverything else: 82 works · 18.5% of their workTHEIR WORKKevin Litchfield441works
Life Sciences52%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology18441.7%
    2. Immunology and Microbiology4610.4%
    1. Medicine13029.4%
  3. Everything else8218.5%
  1. 1Molecular Biology20% of their works
  2. 2Oncology19% of their works
  3. 3Cancer Research17% of their works
  4. 4Pulmonary and Respiratory Medicine11% of their works
  5. 5Immunology10% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Kevin Litchfield's research?

The keywords of their largest research topics: Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Treatment, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Genomics791 topic
  2. Mutational Signatures791 topic
  3. Tumor Microenvironment762 topics
  4. Immune Checkpoint Blockade611 topic
  5. PD-1 and PD-L1611 topic
  6. Treatment452 topics
  7. Dendritic Cells321 topic
  8. Immunity321 topic
  9. Metastatic241 topic
  10. Renal Cell Carcinoma241 topic
  11. Germ Cell Tumors211 topic
  12. Testicular Cancer211 topic
  13. RNA methylation171 topic
  14. m6A-seq171 topic
  15. Sex Determination161 topic
  16. X Chromosome Inactivation161 topic
  17. Cancer151 topic
  18. Ferroptosis151 topic

Where does Kevin Litchfield work?

Kevin Litchfield's main affiliation in the publication record is The Francis Crick Institute, United Kingdom.

How many publications and citations does Kevin Litchfield have?

OpenAlex counts 441 works and 14,806 citations for Kevin Litchfield, an h-index of 53, ranking #12,965 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kevin Litchfield. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.